View gallery.Rumor has it that if the S&P 500 finishes its first five trading days of the year with a gain, then the year in question will — 80 percent of the time — end with a gain as well.Last Thursday’s rally gave the S&P that five-day gain. However, since that day, the market has seen a decent amount of […]
Rumor has it that if the S&P 500 finishes its first five trading days of the year with a gain, then the year in question will — 80 percent of the time — end with a gain as well.Last Thursday’s rally gave the S&P that five-day gain. However, since that day, the market has seen a decent amount of weakness.The […]
It was generally a good year for biotechnology stocks, but the sector remains a risky one. Below are 20 biotechnology companies that lost more than 70% of their value in 2014. (Click here for a list of the best performers.)There aren’t many lessons here. Tolstoy said that happy families are all alike, and but every unhappy family is unhappy in […]
View gallery.It’s been a rough couple of days for biotech stocks.To start, Gilead Sciences, Inc. (NASDAQ: GILD) has dropped from a high of almost $110 per share on Friday to a low of $86 on Tuesday.Many other big-name biotechs, such as Amgen, Inc. (NASDAQ: AMGN), Biogen Idec Inc (NASDAQ: BIIB) and Valeant Pharmaceuticals Intl Inc (NYSE: VRX) have fallen with […]
LONDON, December 22, 2014 /PRNewswire/ –Investor-Edge has initiated coverage on the following equities: Achillion Pharmaceuticals Inc. (NASDAQ: ACHN), Arrowhead Research Corporation (NASDAQ: ARWR), Sunesis Pharmaceuticals Inc. (NASDAQ: SNSS), Array BioPharma Inc. (NASDAQ: ARRY), and Seattle Genetics Inc. (NASDAQ: SGEN). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Friday, December 19, 2014, ended on […]
Many biotech stocks have been breaking out over the past two months.Newlink Genetics Corp and Incyte Corporation both skyrocketed in October.After that, stocks of Ariad Pharmaceuticals, Inc. and Celldex Therapeutics, Inc. both had nice, quick pops last month.Then there was Kite Pharma Inc’s huge jump earlier this month.So, Who’s Next?The Company: Sangamo Biosciences, Inc.Ticker Symbol: (NASDAQ: SGMO)Sector: HealthcareIndustry: BiotechnologySangamo focuses […]
Mark Schoenebaum, the biotech and pharmaceutical analyst at Evercore ISI, asked ;the Twittersphere for their favorite drug stocks going into next year.
What’s your favorite stock for 2015 in biotech or Pharma?
– Mark Schoenebaum (@MarkSchoenebaum) December 12, 2014What was the top pick? A 21-way tie for first place. All 21 companies got a single vote.I kid you not. As I’m writing […]
The Ebola virus has landed in the United States, after Thomas Eric Duncan flew from Liberia to Texas. He was released by a hospital in Dallas, despite telling hospital staff that he came from Liberia. He came in contact with up to 20 people, including 5 schoolchildren since touching down in Dallas. The CDC is monitoring these people, but I have […]
In an interview with Science Friday, Dartmouth’s Jason H. Moore weighs in about Google’s new data collection project, called Baseline Study, which is attempting to paint a picture of human health by cataloging the DNA of healthy people, along with their blood, saliva, tears, and more.
“As a data scientist I am really excited about the Google Baseline Study,” says Moore, […]
Big Data, capitalized for emphasis and hype, is all the rage in every industry. Healthcare is no exception. Companies and investors are betting big on the power of data. Healthcare produces a lot of data that is growing exponentially, so it’s ripe for reaping the benefits of its unification and analysis. I’ve heard a lot of descriptions for Big Data. […]
